The SHM Kentucky Chapter will be hosting a two-day virtual training on Tuesday, September 10th and Wednesday, September 11th at 4:00 p.m. ET. Please join the chapter on September 10th for an educational presentation provided by Dr. Michelle Lofwall and on September 11th for an educational presentation provided by Dr. Anna-Maria South.
Title:
Initiating Medications for Opioid Use Disorder
Hospitalists regularly care for patients with opioid use disorder (OUD), as this is a vulnerable patient population that is overrepresented in the healthcare system. Hospitalizations are a reachable moment to offer treatment for OUD with mortality-reducing medication that has been associated with decreased readmissions. All hospitalists need to be able to diagnose and treat OUD. This four-hour training will be led by two experts in addiction medicine and hospital medicine and will equip you with the necessary skills to initiate medication for opioid use disorder (MOUD) on your patients.
Michelle Lofwall, MD, DFAPA, DFASAM
Dr. Michelle Lofwall, board-certified in psychiatry and addiction medicine, is a Professor in the Departments of Behavioral Science and Psychiatry and the Bell Alcohol and Addictions Endowed Chair at the University of Kentucky (UK). She completed internship, psychiatry residency, and a fellowship in behavioral pharmacology at Johns Hopkins University. Currently, she is the medical director of UK’s Robert Straus and First Bridge Clinics, which provide low barrier comprehensive opioid use disorder (OUD) treatment within the UK Center on Drug and Alcohol Research. Her passion is in improving the care of patients with addiction through research, clinical care, and education.
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Society of Hospital Medicine designates this in-person activity for a maximum of 4.0 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The faculty and planners of these activities have no relevant relationships to disclose. All relevant relationships were mitigated prior to the start of this activity.
Attendees must attend both meetings on September 10th and 11th in order to claim their CME credit.
Click here to register.
Title:
Initiating Medications for Opioid Use Disorder
Hospitalists regularly care for patients with opioid use disorder (OUD), as this is a vulnerable patient population that is overrepresented in the healthcare system. Hospitalizations are a reachable moment to offer treatment for OUD with mortality-reducing medication that has been associated with decreased readmissions. All hospitalists need to be able to diagnose and treat OUD. This four-hour training will be led by two experts in addiction medicine and hospital medicine and will equip you with the necessary skills to initiate medication for opioid use disorder (MOUD) on your patients.
- Screen and identify patients with OUD and define evidence-based treatments.
- Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
- Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
- Explain the process of buprenorphine induction as well as stabilization and maintenance.
- Discuss all FDA approved antagonist and agonists medications to treat OUD. Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine your patients with OUD
Michelle Lofwall, MD, DFAPA, DFASAM
Dr. Michelle Lofwall, board-certified in psychiatry and addiction medicine, is a Professor in the Departments of Behavioral Science and Psychiatry and the Bell Alcohol and Addictions Endowed Chair at the University of Kentucky (UK). She completed internship, psychiatry residency, and a fellowship in behavioral pharmacology at Johns Hopkins University. Currently, she is the medical director of UK’s Robert Straus and First Bridge Clinics, which provide low barrier comprehensive opioid use disorder (OUD) treatment within the UK Center on Drug and Alcohol Research. Her passion is in improving the care of patients with addiction through research, clinical care, and education.
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Society of Hospital Medicine designates this in-person activity for a maximum of 4.0 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The faculty and planners of these activities have no relevant relationships to disclose. All relevant relationships were mitigated prior to the start of this activity.
Attendees must attend both meetings on September 10th and 11th in order to claim their CME credit.
Click here to register.
Date & Time
Tuesday September 10th, 2024 4:00pm EDT
End Date & Time
Tuesday September 10th, 2024 6:00pm EDT
Venue
Zoom Meeting
Category District 7 Chapter Meeting
Event Map
Event Comments